Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Total Liabilities (2016 - 2025)

Historic Total Liabilities for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $43.4 million.

  • InfuSystem Holdings' Total Liabilities fell 1281.38% to $43.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.4 million, marking a year-over-year decrease of 1281.38%. This contributed to the annual value of $46.1 million for FY2024, which is 894.63% down from last year.
  • InfuSystem Holdings' Total Liabilities amounted to $43.4 million in Q3 2025, which was down 1281.38% from $46.3 million recorded in Q2 2025.
  • In the past 5 years, InfuSystem Holdings' Total Liabilities registered a high of $55.0 million during Q2 2024, and its lowest value of $43.4 million during Q3 2025.
  • In the last 5 years, InfuSystem Holdings' Total Liabilities had a median value of $50.6 million in 2023 and averaged $50.2 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first plummeted by 2146.46% in 2021, then soared by 954.28% in 2022.
  • InfuSystem Holdings' Total Liabilities (Quarter) stood at $49.3 million in 2021, then increased by 4.2% to $51.4 million in 2022, then decreased by 1.5% to $50.6 million in 2023, then fell by 8.95% to $46.1 million in 2024, then dropped by 5.8% to $43.4 million in 2025.
  • Its Total Liabilities stands at $43.4 million for Q3 2025, versus $46.3 million for Q2 2025 and $49.1 million for Q1 2025.